The ERGOMED Group is a pan-European Clinical Development Company, providing full clinical trial-related services to developers of medical drugs. ERGOMED can assist with strategic clinical development planning, individual study design, project management and monitoring, study site management, drug safety monitoring and pharmacovigilance, medical writing as well as data management, biostatistics, regulatory assistance and other services. In addition, ERGOMED has access to its own Phase 1 unit for healthy volunteer studies as well as those in special populations and early phase oncology studies.